MEETINGS - RAPS 2001 Europe, the Regulatory Affairs Professionals Society's European event, (Spain) May 2001:
This article was originally published in Clinica
RAPS 2001 Europe, the Regulatory Affairs Professionals Society's European event, will take place in Madrid, Spain, on May 20-23. For more information contact RAPS in the US. Tel: +1 301 770 2920. Fax: +1 770 2924. Email: firstname.lastname@example.org www.raps.org
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.